1076 related articles for article (PubMed ID: 24337819)
21. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
22. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
24. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
26. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic control of gene expression: Potential implications for cancer treatment.
Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
[TBL] [Abstract][Full Text] [Related]
28. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
29. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
30. [Molecular mechanisms involved in epigenetic alterations in cancer].
Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
[TBL] [Abstract][Full Text] [Related]
31. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
32. Curcumin as a regulator of epigenetic events.
Teiten MH; Dicato M; Diederich M
Mol Nutr Food Res; 2013 Sep; 57(9):1619-29. PubMed ID: 23754571
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
34. Review-Epigenetic therapy for cancer.
Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI
Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710
[TBL] [Abstract][Full Text] [Related]
35. DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy.
Brueckner B; Lyko F
Trends Pharmacol Sci; 2004 Nov; 25(11):551-4. PubMed ID: 15491775
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
37. Epigenomics in respiratory epithelium carcinogenesis: prevention and therapeutic challenges.
Karamouzis MV; Konstantinopoulos PA; Papavassiliou AG
Cancer Treat Rev; 2007 May; 33(3):284-8. PubMed ID: 17367937
[TBL] [Abstract][Full Text] [Related]
38. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
[TBL] [Abstract][Full Text] [Related]
40. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
Reamon-Buettner SM; Borlak J
Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
